Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine), CHPE
Gastroenterologist
MBBS, FCPS (Gastroenterology), European Speciality Certificate in Gastroenterology and Hepatalogy (UK)
Gastroenterologist
MBBS, FCPS (Gastroenterology), European Speciality Certificate in Gastroenterology and Hepatalogy (UK)
Dermatologist
M.B.B.S, M.R.C.P (UK)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Gastroenterologist
M.B.B.S., M.D (Gastro), MACG(America)
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
Diabetologist
M.B.B.S, MRCGP, CDE (Certified Diabetes Educator), MCCEE
Internal Medicine Specialist
MBBS, FCPS
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, FACP (USA), FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures